Cargando…
Development of Pre-Clinical Models for Evaluating the Therapeutic Potential of Candidate siRNA Targeting STAT6
Developing siRNA therapeutics poses technical challenges including appropriate molecular design and testing in suitable pre-clinical models. We previously detailed sequence-selection and modification strategies for siRNA candidates targeting STAT6. Here, we describe methodology that evaluates the su...
Autores principales: | Healey, Gareth D., Lockridge, Jennifer A., Zinnen, Shawn, Hopkin, Julian M., Richards, Ivan, Walker, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937390/ https://www.ncbi.nlm.nih.gov/pubmed/24587331 http://dx.doi.org/10.1371/journal.pone.0090338 |
Ejemplares similares
-
Identification of small interfering RNA targeting Signal Transducer and Activator of Transcription 6: Characterisation and selection of candidates for pre-clinical development
por: Healey, Gareth D, et al.
Publicado: (2010) -
Evaluation of nasal epithelium sampling as a tool in the preclinical development of siRNA-based therapeutics for asthma
por: Healey, Gareth D, et al.
Publicado: (2013) -
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
por: Esposito, Carla Lucia, et al.
Publicado: (2017) -
Therapeutic siRNAs Targeting the JAK/STAT Signalling Pathway in Inflammatory Bowel Diseases
por: Clément, Flora, et al.
Publicado: (2021) -
Therapeutic siRNA: state of the art
por: Hu, Bo, et al.
Publicado: (2020)